Julia Frede

766 total citations
11 papers, 283 citations indexed

About

Julia Frede is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Julia Frede has authored 11 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Julia Frede's work include Cancer Genomics and Diagnostics (4 papers), CAR-T cell therapy research (3 papers) and Multiple Myeloma Research and Treatments (3 papers). Julia Frede is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), CAR-T cell therapy research (3 papers) and Multiple Myeloma Research and Treatments (3 papers). Julia Frede collaborates with scholars based in United States, United Kingdom and Germany. Julia Frede's co-authors include Philip H. Jones, Benjamin D. Simons, Philip Greulich, Maria P. Alcolea, Agnieszka Wabik, Tibor Nagy, Scott P. Fraser, Hani Gabra, Gülten Oskay-Özcelik and Elena Ioana Braicu and has published in prestigious journals such as Blood, Nature Cell Biology and Annals of the New York Academy of Sciences.

In The Last Decade

Julia Frede

10 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julia Frede United States	6	200	100	63	38	34	11	283
Malachia Hoover United States	8	138 0.7×	78 0.8×	50 0.8×	22 0.6×	31 0.9×	10	254
Jessica Kalra Canada	11	270 1.4×	88 0.9×	71 1.1×	21 0.6×	54 1.6×	16	404
Frederick D. Park United States	5	227 1.1×	82 0.8×	50 0.8×	15 0.4×	38 1.1×	5	349
Hakki Ogün Sercan Türkiye	10	259 1.3×	97 1.0×	55 0.9×	19 0.5×	29 0.9×	22	364
Patricia A. Eisenach Germany	7	166 0.8×	226 2.3×	104 1.7×	27 0.7×	28 0.8×	7	327
Christiana Hadjimichael Greece	7	342 1.7×	125 1.3×	107 1.7×	31 0.8×	17 0.5×	7	435
Keyur Desai United States	9	149 0.7×	137 1.4×	43 0.7×	53 1.4×	28 0.8×	28	318
Milou Tenhagen Netherlands	9	242 1.2×	133 1.3×	67 1.1×	12 0.3×	60 1.8×	9	334
Daniel E. Foxler United Kingdom	8	203 1.0×	38 0.4×	113 1.8×	21 0.6×	46 1.4×	9	286

Countries citing papers authored by Julia Frede

Since Specialization

Citations

This map shows the geographic impact of Julia Frede's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Frede with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Frede more than expected).

Fields of papers citing papers by Julia Frede

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Frede. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Frede. The network helps show where Julia Frede may publish in the future.

Co-authorship network of co-authors of Julia Frede

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Frede. A scholar is included among the top collaborators of Julia Frede based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Frede. Julia Frede is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Lim, Klothilda, et al.. (2025). Cell-free DNA as a complementary marker of therapeutic futility in adenoid cystic carcinoma. Oral Oncology. 169. 107688–107688.

Waldschmidt, Johannes M., Sankalp Arora, Tushara Vijaykumar, et al.. (2025). Nivolumab to restore T-cell fitness in CAR-T refractory multiple myeloma. Blood Advances. 9(5). 1132–1136. 3 indexed citations

Waldschmidt, Johannes M., Sankalp Arora, Tushara Vijaykumar, et al.. (2022). Nivolumab-Based Salvage Therapy to Restore T Cell Fitness in Penta-Refractory Multiple Myeloma with Relapse to Anti-BCMA CAR T Cell Therapy. Blood. 140(Supplement 1). 9925–9926. 1 indexed citations

Frede, Julia, Hannah T. Stuart, Yana Pikman, et al.. (2022). Single-Cell Multi-Omics Reveals Immune Microenvironment Alterations in T-Cell Acute Lymphoblastic Leukemia. Blood. 140(Supplement 1). 9192–9193. 1 indexed citations

Frede, Julia, Praveen Anand, Ricardo A. Pinto, et al.. (2021). Dynamic transcriptional reprogramming leads to immunotherapeutic vulnerabilities in myeloma. Nature Cell Biology. 23(11). 1199–1211. 26 indexed citations

Frede, Julia, Praveen Anand, Tushara Vijaykumar, et al.. (2019). Defining the differentiation states of multiple myeloma at single cell resolution – Identifying opportunities for immunotherapy. Clinical Lymphoma Myeloma & Leukemia. 19(10). e65–e65. 1 indexed citations

Frede, Julia, Philip Greulich, Tibor Nagy, Benjamin D. Simons, & Philip H. Jones. (2016). A single dividing cell population with imbalanced fate drives oesophageal tumour growth. Nature Cell Biology. 18(9). 967–978. 52 indexed citations

Alcolea, Maria P., Philip Greulich, Agnieszka Wabik, et al.. (2014). Differentiation imbalance in single oesophageal progenitor cells causes clonal immortalization and field change. Nature Cell Biology. 16(6). 612–619. 124 indexed citations

Croagh, Daniel, Julia Frede, Philip H. Jones, et al.. (2014). Esophageal stem cells and genetics/epigenetics in esophageal cancer. Annals of the New York Academy of Sciences. 1325(1). 8–14. 6 indexed citations

10.

Frede, Julia, David J. Adams, & Philip H. Jones. (2014). Mutation, clonal fitness and field change in epithelial carcinogenesis. The Journal of Pathology. 234(3). 296–301. 13 indexed citations

11.

Frede, Julia, Scott P. Fraser, Gülten Oskay-Özcelik, et al.. (2013). Ovarian cancer: Ion channel and aquaporin expression as novel targets of clinical potential. European Journal of Cancer. 49(10). 2331–2344. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact